Company profile

AIT Austrian Institute of Technology GmbH

AIT Austrian Institute of Technology GmbH has 1 AI-enabled medical device on the FDA list. The first decision was on September 27, 2024 and the most recent on September 27, 2024 (encevis (2.1)). Its most common review panel is Neurology (1 device).

1AI devices

2024First decision

2024Latest decision

1Specialties

Timeline

September 27, 2024 · 510(k) K240993encevis (2.1) · Neurology · OMB